-
Je něco špatně v tomto záznamu ?
Role of Nano-miRNAs in Diagnostics and Therapeutics
D. Coradduzza, E. Bellu, A. Congiargiu, A. Pashchenko, E. Amler, A. Necas, C. Carru, S. Medici, M. Maioli
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
35743278
DOI
10.3390/ijms23126836
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- mikro RNA * metabolismus MeSH
- nádory * diagnóza genetika terapie MeSH
- nanomedicína MeSH
- nanotechnologie metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
MicroRNAs (miRNA) are key regulators of gene expression, controlling different biological processes such as cellular development, differentiation, proliferation, metabolism, and apoptosis. The relationships between miRNA expression and the onset and progression of different diseases, such as tumours, cardiovascular and rheumatic diseases, and neurological disorders, are well known. A nanotechnology-based approach could match miRNA delivery and detection to move beyond the proof-of-concept stage. Different kinds of nanotechnologies can have a major impact on the diagnosis and treatment of miRNA-related diseases such as cancer. Developing novel methodologies aimed at clinical practice represents a big challenge for the early diagnosis of specific diseases. Within this context, nanotechnology represents a wide emerging area at the forefront of research over the last two decades, whose potential has yet to be fully attained. Nanomedicine, derived from nanotechnology, can exploit the unique properties of nanometer-sized particles for diagnostic and therapeutic purposes. Through nanomedicine, specific treatment to counteract only cancer-cell proliferation will be improved, while leaving healthy cells intact. In this review, we dissect the properties of different nanocarriers and their roles in the early detection and treatment of cancer.
Department of Biomedical Sciences University of Sassari 07100 Sassari Italy
Department of Chemistry and Pharmacy University of Sassari 07100 Sassari Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017973
- 003
- CZ-PrNML
- 005
- 20220804134505.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms23126836 $2 doi
- 035 __
- $a (PubMed)35743278
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Coradduzza, Donatella $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy $1 https://orcid.org/0000000289780490
- 245 10
- $a Role of Nano-miRNAs in Diagnostics and Therapeutics / $c D. Coradduzza, E. Bellu, A. Congiargiu, A. Pashchenko, E. Amler, A. Necas, C. Carru, S. Medici, M. Maioli
- 520 9_
- $a MicroRNAs (miRNA) are key regulators of gene expression, controlling different biological processes such as cellular development, differentiation, proliferation, metabolism, and apoptosis. The relationships between miRNA expression and the onset and progression of different diseases, such as tumours, cardiovascular and rheumatic diseases, and neurological disorders, are well known. A nanotechnology-based approach could match miRNA delivery and detection to move beyond the proof-of-concept stage. Different kinds of nanotechnologies can have a major impact on the diagnosis and treatment of miRNA-related diseases such as cancer. Developing novel methodologies aimed at clinical practice represents a big challenge for the early diagnosis of specific diseases. Within this context, nanotechnology represents a wide emerging area at the forefront of research over the last two decades, whose potential has yet to be fully attained. Nanomedicine, derived from nanotechnology, can exploit the unique properties of nanometer-sized particles for diagnostic and therapeutic purposes. Through nanomedicine, specific treatment to counteract only cancer-cell proliferation will be improved, while leaving healthy cells intact. In this review, we dissect the properties of different nanocarriers and their roles in the early detection and treatment of cancer.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mikro RNA $x metabolismus $7 D035683
- 650 _2
- $a nanomedicína $7 D050997
- 650 _2
- $a nanotechnologie $x metody $7 D036103
- 650 12
- $a nádory $x diagnóza $x genetika $x terapie $7 D009369
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bellu, Emanuela $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
- 700 1_
- $a Congiargiu, Antonella $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy $1 https://orcid.org/0000000281121298
- 700 1_
- $a Pashchenko, Aleksei $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000313153770
- 700 1_
- $a Amler, Evzen $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic $u University Centre for Energy Efficient Buildings, Czech Technical University in Prague, Trinecka 1024, 273 43 Bustehrad, Czech Republic
- 700 1_
- $a Necas, Alois $u Faculty of Veterinary Medicine, University of Veterinary and Sciences Brno, Palackeho tr. 1946/1, 612 42 Brno, Czech Republic
- 700 1_
- $a Carru, Ciriaco $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy $1 https://orcid.org/0000000269854907
- 700 1_
- $a Medici, Serenella $u Department of Chemistry and Pharmacy, University of Sassari, 07100 Sassari, Italy $1 https://orcid.org/0000000243040251
- 700 1_
- $a Maioli, Margherita $u Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy $u Center for Developmental Biology and Reprogramming (CEDEBIOR), Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy $1 https://orcid.org/0000000301874968 $7 xx0271022
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 12 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35743278 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134459 $b ABA008
- 999 __
- $a ok $b bmc $g 1821859 $s 1169216
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 12 $e 20220620 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20220720